Disenhaus C, Belair L, Djiane J
Laboratoire de Physiologie de la Lactation, I.N.R.A., Jouy-en-Josas, France.
Reprod Nutr Dev (1980). 1988;28(2A):241-52.
Membrane preparations were obtained by differential centrifugations of ewe mammary gland homogenates. These membrane preparations contained specific receptors for IGF1 and IGF2 which possess high affinities for their specific ligands (Ka .5 to 1.5 10(9) M-1). Maximum binding of 125I IGF1 was obtained after 48 h at 4 degrees C. This binding was inhibited by unlabelled IGF1 (ED50 = 14 ng/ml), partially inhibited by high concentrations of insulin (50 micrograms/ml). Prolactin (oPRL), growth hormone (bGH) or relaxin (Rel) were without effect. Maximum binding of 125I IGF2 was obtained after 6 h at 20 degrees C. This binding was inhibited by unlabelled IGF2 (ED50 = 44 ng/ml), partially inhibited by IGF1 (ED50 = 200 ng/ml) and unmodified by INS, PRL, bGH or Rel. Receptor numbers for IGF1 were significantly higher (p less than 0.01) on day 100 of pregnancy (N = 480 +/- 17 fmoles/mg proteins) compared to day 20 of lactation (N = 174 +/- 21 fmoles/mg). The numbers of IGF2 receptors were always higher than those of IGF1 receptors. During pregnancy the numbers of IGF2 receptors (N = 1,860 +/- 157 fmoles/mg) were also higher than during lactation. These results suggest that the mammary gland may constitute a target organ for IGFs. These factors could be involved in the regulation of mammary gland development and during cell differentiation.
通过对母羊乳腺匀浆进行差速离心获得膜制剂。这些膜制剂含有IGF1和IGF2的特异性受体,它们对其特异性配体具有高亲和力(Ka为0.5至1.5×10⁹ M⁻¹)。在4℃下48小时后获得¹²⁵I IGF1的最大结合。这种结合被未标记的IGF1抑制(ED50 = 14 ng/ml),被高浓度胰岛素(50μg/ml)部分抑制。催乳素(oPRL)、生长激素(bGH)或松弛素(Rel)无作用。在20℃下6小时后获得¹²⁵I IGF2的最大结合。这种结合被未标记的IGF2抑制(ED50 = 44 ng/ml),被IGF1部分抑制(ED50 = 200 ng/ml),且不受INS、PRL、bGH或Rel影响。与泌乳第20天(N = 174±21 fmol/mg)相比,妊娠第100天IGF1的受体数量显著更高(p<0.01)(N = 480±17 fmol/mg蛋白质)。IGF2受体的数量总是高于IGF1受体的数量。在妊娠期间,IGF2受体的数量(N = 1860±157 fmol/mg)也高于泌乳期间。这些结果表明乳腺可能是IGF的靶器官。这些因子可能参与乳腺发育和细胞分化的调节。